Quantcast

Latest Growth hormone secretagogue receptor Stories

Hunger Hormone Prevents PTSD
2013-10-16 10:41:24

Michael Harper or redOrbit.com - Your Universe Online Researchers from the Massachusetts Institute of Technology (MIT) say drugs created to suppress appetite may also be effective in preventing post-traumatic stress disorder (PTSD). At the heart of the research is ghrelin, what many refer to as the “hunger hormone.” When this hormone was found to trigger appetite in humans, many drug manufacturers set about creating drugs to block the biochemical as a way to prevent obesity. Yet as...

2012-06-25 21:06:04

A new study suggests that the appetite-inducing hormone ghrelin increases the incentive for humans to eat high-calorie foods, even on a full stomach. The results will be reported Sunday at The Endocrine Society's 94th Annual Meeting in Houston. In the study, rats lacking the ghrelin receptor gene ate less of a sweet treat after a full meal than did rodents whose ghrelin receptor gene was intact. "Combined with an increasingly sedentary lifestyle, overconsumption of reward-driven foods...

2012-01-26 02:08:43

New research reveals a fascinating and unexpected molecular partnership within the brain neurons that regulate appetite. The study, published by Cell Press in the January 26 issue of the journal Neuron, resolves a paradox regarding a receptor without its hormone and may lead to more specific therapeutic interventions for obesity and disorders of dopamine signaling. Ghrelin is an appetite-stimulating hormone produced by the stomach. Although the ghrelin receptor (GHSR1a) is broadly...

2011-05-09 07:00:00

BOSTON, May 9, 2011 /PRNewswire/ -- Rhythm announced today results demonstrating that RM-131, the company's novel ghrelin agonist, was highly effective in restoring normal gastric function in animal models of delayed gastric emptying owing to a direct prokinetic effect. The results were the subject of an oral presentation by Lee M. Kaplan, MD, PhD (Massachusetts General Hospital, Harvard Medical School) titled "RM-131: A Potent Gastroprokinetic Agent" at the Digestive Disease Week 2011...

2010-12-13 06:03:43

(Ivanhoe Newswire) -- Deleting the receptor, not the protein ghrelin itself, turns up the body's fat-burning thermostat, giving aging mice an exothermic boost toward a svelte physique, researchers recently reported. The protein's receptor, growth hormone secretagogue receptor (GHS-R), might make a better target than ghrelin for treating obesity, according to Sun said that experimentally deleting the receptor from the body cells of laboratory mice prevented obesity by diminishing white adipose...

2010-09-28 06:30:00

President and CEO, Juergen Engel, Ph.D., to present corporate overview at upcoming BioContact in Quebec City QUEBEC CITY, Sept. 28 /PRNewswire-FirstCall/ - Aeterna Zentaris Inc. (NASDAQ: AEZS, TSX: AEZ), ("the Company") a late-stage drug development company specialized in oncology and endocrinology, today announced that a poster on its oral synthetic growth hormone secretagogue/ghrelin receptor agonist, AEZS-130 (macimorelin, Solorel(TM)), will be presented at the upcoming 5th International...

2010-07-08 06:30:00

QUEBEC CITY, July 8 /PRNewswire-FirstCall/ - Aeterna Zentaris Inc. (Nasdaq: AEZS; TSX: AEZ), (the "Company") a late-stage drug development company specialized in oncology and endocrine therapy, today announced that a poster on its oral synthetic growth hormone secretagogue/ghrelin receptor agonist, AEZS-130, will be presented at the upcoming 7th International Congress of Neuroendocrinology, which will be held July 11 through 15, 2010, in Rouen, France. AEZS-130 (Solorel(TM)) is currently in a...

2010-06-14 13:11:00

QUEBEC CITY, June 14 /PRNewswire-FirstCall/ - Aeterna Zentaris Inc. (Nasdaq: AEZS; TSX: AEZ), (the "Company") a late-stage drug development company specialized in oncology and endocrine therapy, today announced that a poster on its oral synthetic growth hormone secretagogue/ghrelin receptor agonist, AEZS-130, will be presented at the upcoming 92nd Annual Endocrine Society (ENDO) Meeting and Expo, which will be held June 19 through 22, 2010 at the San Diego Convention Center in San Diego,...

2009-11-25 15:11:20

Ghrelin, a hormone produced in the stomach, may be used to boost resistance to, or slow, the development of Parkinson's disease, Yale School of Medicine researchers report in a study published in a recent issue of the Journal of Neuroscience. Parkinson's disease is caused by a degeneration of dopamine neurons in an area of the midbrain known as the substantia nigra, which is responsible for dopamine production. Reduced production of dopamine in late-stage Parkinson's causes symptoms such as...


Word of the Day
penuche
  • A fudgelike confection of brown sugar, cream or milk, and chopped nuts.
'Penuche' is a variant of 'panocha,' a coarse grade of sugar made in Mexico. 'Panocha' probably comes from the Spanish 'panoja, panocha,' ear of grain.
Related